MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION Read more about MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION Patent Cooperation TreatyPCT/US2023/084255Filed on 2023-12-15
STABILIZED PFS48/45 PROTEINS AND USES THEREOF Read more about STABILIZED PFS48/45 PROTEINS AND USES THEREOF Patent Cooperation TreatyPCT/US2023/085849Filed on 2023-12-22
Anti-Coronavirus Antibodies And Methods Of Use Read more about Anti-Coronavirus Antibodies And Methods Of Use Pakistan855/2020Filed on 2020-12-14
USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION Read more about USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US Application 18/538,065Filed on 2023-12-13
Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization Read more about Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization Hong KongNoneFiled on 2014-02-07
Development Of Dengue Virus Vaccine Components Read more about Development Of Dengue Virus Vaccine Components Australia2023255035Filed on 2023-10-27
NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) Read more about NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) Patent Cooperation TreatyPCT/US2023/082822Filed on 2023-12-07
PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE Read more about PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE US Application 18/557,396Filed on 2023-10-26
PREFUSION RSV F PROTEINS AND THEIR USE Read more about PREFUSION RSV F PROTEINS AND THEIR USE US Application 18/409,645Filed on 2024-01-10